France Digital Health Market Analysis Report [2022-30] I Insights10

France Digital Health Market Analysis

$ 3999

The France Digital Health market is projected to grow from $ 5.8Bn in 2022 to $ 21.23Bn by 2030, registering a CAGR of 17.6% during the forecast period of 2022 - 2030. The market seems to be driven by supportive government policies, private digital health investments, and growing demands of the same. The market is segmented by solution, by deployment & by end-use. Some of the major players include Doctolib, Owkin & Meditech.

ID: IN10FRDH005 CATEGORY: Digital Health GEOGRAPHY: France

Buy Now

France Digital Health Market Executive Summary

The France Digital Health market is projected to grow from $ 5.8Bn in 2022 to $ 21.23Bn by 2030, registering a CAGR of 17.6% during the forecast period of 2022 - 2030. France's healthcare spending for 2019 was $4,492(11.6%), a 3.56% decline from 2018 and dropped even further in 2020 owing to the COVID- 10 pandemic. Although it is expected to grow in the future as the impact of the pandemic subsides. The French government develops the national health policy and assigns allocated funds to regional health agencies, which are in charge of both planning and service delivery.

In terms of the number of Digital Health businesses launched between 2010 and 2020, France is Europe's second-largest single national market. Software for screening and diagnostics are among the most promising areas of France's Digital Health. However, telemedicine and remote patient monitoring have also evolved as important due to the pandemic's societal shifts.

AI and robotics-based fertility care solutions are in the budding stage with new businesses such as Apricity & Mojo emerging to provide virtual reproductive and fertility care solutions. The Health Data Hub was established in France with the purpose of acquiring and compiling data in order to make French health data available for clinical and medical research and to enhance patient care. It has taken lead to a European consortium formed to plan the future implementation of the European Health Data Space.

France digital health market analysis

Market Dynamics

Market Growth Drivers

The government of France launched a “My Health” plan in 2020 that has expedited healthcare digitalization by creating a Digital Health Space for patients. The continuous evolution of technologies such as AI and ML, 5G, IoT, and Blockchain are providing new opportunities for digital healthcare innovation and growth. Moreover, the Outbreak of the COVID -19 pandemic accelerated the adoption of digital health technologies in France. An increase in capital funding and investments by both corporate and private sectors has been shown to raise funding in the digital health market for France. Other common factors for the growth of the market include aging population, an increase in demand for self-care options, healthcare cost reduction, and increasing patient engagement by the population of France.

Market Restraints

Some digital healthcare technologies may not be fully covered by the French National Health Insurance system, which may limit their adoption by patients and healthcare providers. There may be challenges in integrating and sharing data across different platforms considering the number of different digital healthcare systems in use. Security of patient data and the risk of cyber-attacks also become major factors restricting the market growth if not addressed well. Moreover, a lack of digital literacy and limited access to digital technologies in some rural areas could hinder the adoption of digital health options in some areas.

Competitive Landscape

Key Players

Doctolib (FRA): Is planning to come up with an instant messaging service for healthcare consultants to securely talk about patients and share4 documents.
Owkin (FRA): November 2021: Owkin partnered with Sanofi, one of the largest pharmaceutical companies in the world, to use AI and ML to accelerate drug discovery and development.
Meditech (FRA): September 2022, came up with a project to propose tools to aid the use if digital medical devices for professional use.
Mckesson Corporation (USA): January 2019: extended their relations with Genpact which delivers services for digital transformations.
Telefónica S.A. (ESP)

Healthcare Policies and Regulatory Landscape

In France, the Ministry of Health's Délégation du Numérique en Santé (Digital Health Delegation) has created a comprehensive strategy for the adoption of digital health technologies. They are in charge of ensuring the execution of digital health transformation initiatives throughout France, from primary care offices to hospitals. In 2019, the French government established the National Artificial Intelligence (AI) Strategy which aims to support the development and use of AI in healthcare.

Reimbursement Scenario

The French National Health Insurance System (Sécurité Sociale) uses medical efficacy and expense of digital health technology to determine reimbursement. The Haute Autorité de Santé (HAS), the national body in charge of determining the medical value of healthcare products and services, oversees the reimbursement process. Digital health goods and services that are registered with the French National Agency for Medicines and Health Products Safety (ANSM) and conform to applicable rules become eligible to be reimbursed.

1. Executive Summary
1.1 Digital Health Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Digital Health Policy in Country
1.6 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Digital Health Market Segmentation

The Digital Health Market is segmented as mentioned below:

By Solution (Revenue, USD Billion):

Software
Services

By Deployment (Revenue, USD Billion):

Cloud-based
On-premises

By End-use (Revenue, USD Billion):

Diagnostic Centres
Healthcare Payers
Healthcare Research Centres
Hospitals & Clinics
Nursing Care Centres
Others

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.